Press release
U.S. Point-of-Care Diagnostics Market Set to Reach $13.16 Billion by 2030
Meticulous Research® Unveils Comprehensive Insights in Latest Report on U.S. Point-of-Care Diagnostics Market
Meticulous Research®, a prominent global market research firm, has released an in-depth research report titled, "U.S. Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker), Platform (LFA, Molecular), Sample (Blood, Urine), End User - Forecast to 2030."
Download Sample Report Here https://www.meticulousresearch.com/download-sample-report/cp_id=5730
In this latest publication from Meticulous Research®, the U.S. point-of-care diagnostics market is projected to showcase a Compound Annual Growth Rate (CAGR) of 4.3% from 2023, reaching an impressive valuation of $13.16 billion by the year 2030. The market's growth trajectory is attributed to groundbreaking advancements in Point-of-Care (POC) tests, increasing commercialization of Clinical Laboratory Improvement Amendments (CLIA)-waived POC tests, augmented research and development funding, heightened awareness concerning early disease diagnosis, and a surge in chronic diseases prevalent among the aging population. However, challenges such as stringent regulatory policies and pricing pressures due to reimbursement fluctuations pose impediments to market growth.
Market Dynamics
The report underscores the pivotal role of innovation in POC tests, emphasizing the growing commercialization of CLIA-waived POC tests. Furthermore, the surge in funding for research and development, the rise in awareness regarding early disease diagnosis, and the increasing prevalence of chronic diseases are key drivers fueling the U.S. point-of-care diagnostics market. Despite these positive factors, the market faces challenges in the form of stringent regulatory policies and pricing pressures resulting from reimbursement fluctuations.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/us-point-of-care-diagnostics-market-5730
Amidst these challenges, the U.S. point-of-care diagnostics market is poised for significant growth opportunities, driven by escalating investments in healthcare infrastructure and a growing preference among healthcare professionals for POC tests over traditional lab tests.
Key Players Shaping the Market
The report highlights key players influencing the U.S. point-of-care diagnostics market, including Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), QuidelOrtho Corporation (U.S.), Sekisui Diagnostics, LLC. (U.S.), Chembio Diagnostics, Inc. (U.S.), EKF Diagnostics Holdings plc (U.K.), Trinity Biotech plc (Ireland), Werfen (Spain), and Nova Biomedical (U.S.).
Future Outlook
The U.S. point-of-care diagnostics market is meticulously analyzed in the report based on offering, platform, application, sample type, and end user. The consumables segment is anticipated to hold the largest share in 2023, driven by the recurrent use of consumables in disease detection, increased product approvals, and technological advancements in ELISpot assay kits.
Have Any Query ? Speak To Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5730
Molecular diagnostics is projected to register the highest CAGR, emphasizing its high sensitivity, accuracy, and wide applications across various fields. In 2023, blood glucose monitoring is expected to dominate the market among applications, with a significant market share attributed to the rising prevalence of diabetes and increased consumer awareness.
The blood sample type segment is forecasted to exhibit the highest CAGR, owing to the availability of a wide variety of tests using blood samples and the increasing prevalence of chronic diseases. In terms of end-users, hospitals are anticipated to account for the largest share in 2023, fueled by various tests performed to diagnose medical conditions, coupled with the increasing healthcare expenditure.
For further insights and a detailed analysis, please refer to the complete "U.S. Point-of-Care Diagnostics Market by Meticulous Research® - Forecast to 2030" report.
Download Sample Report Here https://www.meticulousresearch.com/download-sample-report/cp_id=5730
Related Research:
1. Point of care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Global Forecast to 2030 https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871
2. Asia-Pacific Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Forecast to 2030 https://www.meticulousresearch.com/product/asia-pacific-point-of-care-diagnostics-market-5671
3. Europe Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis) Platform (LFA, Molecular) Sample, and End User - Forecast to 2030 https://www.meticulousresearch.com/product/europe-point-of-care-diagnostics-market-5650
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.
Meticulous Research®, a prominent global market research firm, has released an in-depth research report titled, "U.S. Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker), Platform (LFA, Molecular), Sample (Blood, Urine), End User - Forecast to 2030."
Download Sample Report Here https://www.meticulousresearch.com/download-sample-report/cp_id=5730
In this latest publication from Meticulous Research®, the U.S. point-of-care diagnostics market is projected to showcase a Compound Annual Growth Rate (CAGR) of 4.3% from 2023, reaching an impressive valuation of $13.16 billion by the year 2030. The market's growth trajectory is attributed to groundbreaking advancements in Point-of-Care (POC) tests, increasing commercialization of Clinical Laboratory Improvement Amendments (CLIA)-waived POC tests, augmented research and development funding, heightened awareness concerning early disease diagnosis, and a surge in chronic diseases prevalent among the aging population. However, challenges such as stringent regulatory policies and pricing pressures due to reimbursement fluctuations pose impediments to market growth.
Market Dynamics
The report underscores the pivotal role of innovation in POC tests, emphasizing the growing commercialization of CLIA-waived POC tests. Furthermore, the surge in funding for research and development, the rise in awareness regarding early disease diagnosis, and the increasing prevalence of chronic diseases are key drivers fueling the U.S. point-of-care diagnostics market. Despite these positive factors, the market faces challenges in the form of stringent regulatory policies and pricing pressures resulting from reimbursement fluctuations.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/us-point-of-care-diagnostics-market-5730
Amidst these challenges, the U.S. point-of-care diagnostics market is poised for significant growth opportunities, driven by escalating investments in healthcare infrastructure and a growing preference among healthcare professionals for POC tests over traditional lab tests.
Key Players Shaping the Market
The report highlights key players influencing the U.S. point-of-care diagnostics market, including Abbott Laboratories (U.S.), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), QuidelOrtho Corporation (U.S.), Sekisui Diagnostics, LLC. (U.S.), Chembio Diagnostics, Inc. (U.S.), EKF Diagnostics Holdings plc (U.K.), Trinity Biotech plc (Ireland), Werfen (Spain), and Nova Biomedical (U.S.).
Future Outlook
The U.S. point-of-care diagnostics market is meticulously analyzed in the report based on offering, platform, application, sample type, and end user. The consumables segment is anticipated to hold the largest share in 2023, driven by the recurrent use of consumables in disease detection, increased product approvals, and technological advancements in ELISpot assay kits.
Have Any Query ? Speak To Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5730
Molecular diagnostics is projected to register the highest CAGR, emphasizing its high sensitivity, accuracy, and wide applications across various fields. In 2023, blood glucose monitoring is expected to dominate the market among applications, with a significant market share attributed to the rising prevalence of diabetes and increased consumer awareness.
The blood sample type segment is forecasted to exhibit the highest CAGR, owing to the availability of a wide variety of tests using blood samples and the increasing prevalence of chronic diseases. In terms of end-users, hospitals are anticipated to account for the largest share in 2023, fueled by various tests performed to diagnose medical conditions, coupled with the increasing healthcare expenditure.
For further insights and a detailed analysis, please refer to the complete "U.S. Point-of-Care Diagnostics Market by Meticulous Research® - Forecast to 2030" report.
Download Sample Report Here https://www.meticulousresearch.com/download-sample-report/cp_id=5730
Related Research:
1. Point of care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Global Forecast to 2030 https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871
2. Asia-Pacific Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis), Platform (LFA, Molecular), Sample, End User - Forecast to 2030 https://www.meticulousresearch.com/product/asia-pacific-point-of-care-diagnostics-market-5671
3. Europe Point-of-Care Diagnostics Market by Application (Influenza, Pneumonia, TB, HAI, Salmonellosis, Hepatitis, HIV, COVID, Pregnancy, Glucose Monitoring, Hematology, Tumor Marker, Urinalysis) Platform (LFA, Molecular) Sample, and End User - Forecast to 2030 https://www.meticulousresearch.com/product/europe-point-of-care-diagnostics-market-5650
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
